In breast cancer, NUDT5 overexpression not only increases ATP synthesis and reconstructs tumor cell chromosomes [20], it also activates the AKT pathways and increases the expression of Cyclin D1, which promotes cancer cell resistance to ER-targeting drugs. This evidence concerns the gene AKT1 and cancer.